Search Results (7,666)

The widespread use of anticancer drugs (ACDs) in human therapies determines the occurrence of these potent cytotoxic chemicals into aquatic ecosystems. Nowadays, ACDs are ubiquitous contaminants in wastewater effluents and freshwater compartments, raising urgent questions about their environmental impact. Designed to disrupt cellular proliferation, these compounds are inherently bioactive and can exert toxic effects on non-target organisms even at trace concentrations. Conventional fate and toxicity tests provide important initial data but are limited in ecological realism, often focusing on single-specie and single-endpoint under controlled conditions and overlooking complex interactions, trophic dynamics, and long-term chronic exposures. Knowledge of all these aspects is needed for proper monitoring, assessment, and regulation of ACDs. Simulated ecosystem experiments, such as mesocosms, provide intermediate-scale, semi-controlled platforms for investigating real-world exposure scenarios, assessing ACD fate, and identifying both direct and indirect ecological effects. They offer distinct advantages for evaluating the chronic toxicity of persistent pollutants by enabling realistic long-term contamination simulations and supporting the simultaneous collection of comprehensive hazard and exposure endpoints. This perspective underscores the growing concern surrounding the contamination of ACDs, examines the limitations of traditional assessment approaches, and advocates for mesocosm-based studies as a critical bridge between laboratory research and ecosystem-level understanding. By integrating mesocosm experiments into environmental fate and risk evaluation, we can better predict the behavior and ecological consequences of anticancer pharmaceuticals, guiding strategies to mitigate their impact on aquatic life. Full article

Cancer remains one of the leading causes of morbidity and mortality worldwide, demanding the continuous search for novel and more selective chemotherapeutic agents. Quinones, particularly naphthoquinones, constitute a privileged class of redox-active compounds with well-documented antitumor activity. Likewise, thiazoles represent a heterocyclic scaffold widely explored in medicinal chemistry due to their broad pharmacophoric adaptability and diverse biological activities. In this context, this review comprehensively explores the chemical synthesis and anticancer potential of hybrid molecules combining the naphthoquinone and thiazole scaffolds. The hybridization of these pharmacophores has emerged as a powerful strategy to design multitarget antitumor agents. The review summarizes key synthetic methodologies, including Hantzsch, hetero Diels–Alder cycloaddition and multicomponent reactions, leading to structurally diverse hybrids. Particular emphasis is placed on derivatives exhibiting strong cytotoxic effects against a broad spectrum of cancer cell lines (e.g., OVCAR3, MCF-7, A549, HCT-116, HeLa, and Jurkat), low toxicity toward normal cells and well-defined mechanisms of action involving topoisomerase IIα, EGFR, STAT3, and CDK1 inhibition, as well as ROS generation and cell cycle arrest. Among these, certain hybrids displayed nanomolar potency and high selectivity indices, reinforcing their potential as promising lead compounds for anticancer drug development. Full article

The COVID-19 outbreak has had a tremendous socioeconomic impact around the world, and although there are currently some drugs that have been granted authorization by the U.S. FDA for the treatment of COVID-19, there are still some restrictions on their use. As a result, it is still necessary to urgently carry out related drug development research. Deep generative models and cheminformatics were used in this study to design and screen novel candidates for potential anti-SARS-CoV-2 small molecule compounds. In this study, the small molecule structure of Molnupiravir which has been authorized by the U.S. FDA for emergency use was used to be a model in a similarity search based on the BIOVIA Available Chemicals Directory (BIOVIA ACD) database using the BIOVIA Discovery Studio (DS) software (version 2022). There were 61,480 similar structures of Molnupiravir, which were used as training dataset for the deep generative model, and then the reinforcement learning model was used to generate 6000 small molecule structures. To further confirm whether those molecule structures potentially possess the ability of anti-SARS-CoV-2, cheminformatics techniques were used to assess 38 small molecule compounds with potential anti-SARS-CoV-2 activity. The suitability of 38 small molecule structures was calculated using ADMET analysis. Finally, one compound structure, Molecule_36, passed ADMET and was unpatented. This study demonstrates that Molecule_36 may have better potential than Molnupiravir does in affinity with SARS-CoV-2 RdRp and ADMET. We provide a combination of generative deep neural networks and cheminformatics for developing new anti-SARS-CoV-2 compounds. However, additional chemical refinement and experimental validation will be required to determine its stability, mechanism of action, and antiviral efficacy. Full article

Agricultural and agro-industrial residues are increasingly recognized as sustainable, low-cost feedstocks for high-performance biomedical materials. This review critically examines the translational potential of polysaccharides, proteins, inorganic compounds, and phytochemical-rich extracts derived from agro-waste, highlighting their chemical features, structure–function relationships, and application-specific readiness. Polysaccharides such as nanocellulose, pectin, and chitosan emerge as the most advanced biopolymer platforms, particularly in wound healing, drug delivery, and 3D-printed scaffolds. Protein-derived materials—including collagen, gelatin, keratin, and soy protein—show strong promise in regenerative medicine, though challenges in mechanical stability and batch reproducibility remain. Inorganic phases such as hydroxyapatite and silica obtained from eggshells, rice husk ash, and marine shells demonstrate high bioactivity, with dental and bone applications approaching clinical translation. Finally, fruit-residue phytochemicals provide multifunctional antioxidant and antimicrobial enhancements to composite systems. By integrating material chemistry, processing strategies, and translational considerations, this review outlines the current state, challenges, and future perspectives for advancing agro-waste-derived biomaterials within a circular bioeconomy. Full article

Mannans are structurally composed of β-(1 → 4)-linked mannose units, which are widely distributed in plant cell walls, yeast, and bacterial exopolysaccharides. Mannans have emerged as multipurpose biopolymers with significant industrial and biomedical potential. Celebrated mannans include guar gum, locust bean gum, konjac glucomannan, yeast mannans, and softwood glucomannans. This comprehensive review highlights the sources, structural diversity, extraction methods, physicochemical properties, safety, and functional characteristics. The major bioactivities of mannans, including immunomodulatory, antioxidative, and prebiotic effects, reflect their relevance in biopharmaceutical applications. Moreover, mannans serve as valuable raw materials for developing biodegradable films, hydrogels, and nanocomposites applied in sustainable materials and drug delivery systems. Despite promising applications, challenges related to their large-scale production, standardization, and functional optimization remain to be investigated. Future perspectives focus on integrating advanced biotechnological approaches and chemical modifications to enhance the functional versatility of mannans. Overall, mannans represent a sustainable, multifunctional biopolymer with expanding applications across food, pharmaceutical, and biomedical industries. Full article

Background/Objectives: Due to their biocompatibility and bone-like composition, calcium phosphate materials—especially hydroxyapatite (HAp)—have emerged as promising carriers for localized antibiotic delivery in bone regeneration. Here, we developed Hap-based composite microspheres using a simple wet-chemical method and incorporated multiple antibiotics to evaluate their release profiles and antibacterial potential for treating bone infections. Methods: In this study, uniform and porous composite microspheres composed of Hap and gelatin were synthesized via a simple wet-chemical method using a mixed calcium phosphate–gelatin solution. Results: The resulting gelatin–Hap microspheres (G-HAM) were systematically characterized to verify their crystalline structure, morphology, composition, and thermal stability. G-HAM exhibited a highly porous structure, making them well-suited for use as drug carriers. Four clinically relevant antibiotics—gentamicin, vancomycin, teicoplanin, and zyvox—were incorporated into the microspheres and evaluated for their release behavior and antibacterial performance against Staphylococcus aureus. The release profiles revealed an initial burst release within the first hour that exceeded the minimum inhibitory concentrations of all tested antibiotics, followed by a sustained release phase. Antibiotics containing carboxylic groups, such as vancomycin and teicoplanin, demonstrated stronger interactions with Hap, resulting in a more prolonged release. Antibacterial testing confirmed that the released antibiotics maintained their chemical stability and bioactivity. Furthermore, the combination of bioactive Hap and peptide-rich gelatin promoted osteoblast-like cell adhesion and proliferation, while cytotoxicity assays verified excellent biocompatibility. Conclusions: Overall, these G-HAM provide a promising platform that integrates controlled antibiotic release with osteoconductive potential for bone infection treatment and tissue regeneration. Full article

Background/Objectives: Cell-mediated and peptide-assisted delivery systems have emerged as powerful platforms at the intersection of chemistry, nanotechnology, and molecular medicine. By leveraging the intrinsic targeting, transport, and signaling capacities of living cells and bioinspired peptides, these systems facilitate the delivery of therapeutic agents across otherwise restrictive biological barriers such as the blood–brain barrier (BBB) and the tumor microenvironment. This review aims to summarize recent advances in engineered cell carriers, peptide vectors, and hybrid nanostructures designed for enhanced intracellular and tissue-specific delivery. Methods: We surveyed recent literature covering molecular design principles, mechanistic studies, and in vitro/in vivo evaluations of cell-mediated and peptide-enabled delivery platforms. Emphasis was placed on neuro-oncology, immunotherapy, and regenerative medicine, with particular focus on uptake pathways, endosomal escape mechanisms, and structure–function relationships. Results: Analysis of current strategies reveals significant progress in optimizing cell-based transport systems, peptide conjugates, and multifunctional nanostructures for the targeted delivery of drugs, nucleic acids, and immunomodulatory agents. Key innovations include improved BBB penetration, enhanced tumor homing, and more efficient cytosolic delivery enabled by advanced peptide designs and engineered cellular carriers. Several platforms have progressed toward clinical translation, underscoring their therapeutic potential. Conclusions: Cell-mediated and peptide-assisted delivery technologies represent a rapidly evolving frontier with broad relevance to next-generation therapeutics. Despite notable advances, challenges remain in scalability, manufacturing, safety, and regulatory approval. Continued integration of chemical design, molecular engineering, and translational research will be essential to fully realize the clinical impact of these delivery systems. Full article

Fritillaria pallidiflora Schrenk ex Fisch. & C.A.Mey. (Yi Beimu) is a culturally significant Beimu drug in Northwest China, officially listed in the Chinese Pharmacopoeia and traditionally used to clear heat, moisten the lung, resolve phlegm, and relieve cough and wheeze. This narrative, critical review synthesizes current evidence on ethnopharmacology, phytochemistry, pharmacology, pharmacokinetics/toxicology, and conservation of F. pallidiflora to support sustainable, evidence-based development. Literature was retrieved from major English and Chinese databases and screened for studies that unambiguously involved Yi Beimu or its key constituents. Ethnomedicinal records consistently support antitussive, expectorant, and anti-asthmatic use in Xinjiang and the Ili River Valley. Chemically, F. pallidiflora is rich in cevanine-type steroidal alkaloids (e.g., imperialine, peimine, yibeinones), steroidal saponins (pallidiflosides), polysaccharides, and minor phenolics. Preclinical data show that alkaloids relax airway smooth muscle, suppress inflammatory mediators, and contribute to antitussive and anti-asthmatic effects, while polysaccharides and total alkaloid extracts exhibit antioxidant and cytoprotective activity in cell and animal models of airway injury. Additional studies report cytotoxic saponins and seed-derived antimicrobial peptides. Pharmacokinetic work highlights low to moderate and variable oral bioavailability, shaped by P-glycoprotein efflux and CYP-mediated metabolism, and reveals potential hERG channel inhibition for peimine as a cardiac safety concern. Overharvesting and habitat loss have reduced wild resources, underscoring the need for conservation, cultivation, and marker-guided quality control. Overall, Yi Beimu shows credible ethnopharmacological rationale and promising multi-target pharmacology for respiratory disorders, but translation will require bioactivity-guided isolation coupled with PK–PD-guided in vivo studies, rigorous safety evaluation, and conservation-aware cultivation to move from traditional remedy toward validated therapeutic resource. Full article

Plant-derived extracellular vesicles (PEVs) have emerged as a promising area of research in biotechnology with enormous potential in drug delivery, skincare, and functional foods. Currently, PEVs are obtained primarily from fresh and dried materials through soaking and extraction; however, little is known about the differences in their contents. Using Portulaca oleracea L. as the research object, this study firstly employed a method that combined differential and ultracentrifugation with membrane filtration to separate and purify exosome-like nanoparticles from dried material (D-PELNs) and fresh material (F-PELNs). Then, multi-omics analysis compared the small-molecule metabolites, lipid profiles, and protein expression patterns. Both D-PELNs and F-PELNs showed typical cup-shaped morphology, with mean particle sizes of 139 nm and 186 nm, and mean zeta potentials of −16.015 ± 0.335 mV and −6.29 ± 0.19 mV, respectively. Both types contained diverse small-molecule metabolites. Among them, terpenoids (e.g., caesaldekarin e) were more abundant in F-PELNs, whereas carboxylic acids and their derivatives (e.g., citric acid) were predominantly found in D-PELNs. Both types had abundant lipids. D-PELNs exhibited greater lipid diversity than F-PELNs, with notable enrichment in phosphatidylcholine (18.48%) and ceramide (17.02%). F-PELNs mainly consisted of functional neutral lipids, such as monoglycerides and triglycerides. Proteins involved in plant morphogenesis and secondary-metabolite biosynthesis were also identified. Proteins from both Portulaca oleracea L.-derived exosome-like nanoparticles (PELNs) were localized to intracellular structures, including the cytoplasm and mitochondria of the cells. D-PELNs had a higher protein content related to carbon metabolism, whereas F-PELNs were more enriched in proteins related to secondary metabolite synthesis. In summary, D-PELNs and F-PELNs were successfully isolated and characterized, and their compositions were analyzed and compared using multi-omics approaches. These findings identify the specific chemical components of PELNs and offer new insights for comparing the compositional differences between exosome-like nanoparticles derived from dried and fresh plant states. Full article

Bacterial biofilms pose significant challenges in clinical, industrial, and environmental settings due to their inherent resistance to antimicrobial agents and host immune responses. Encased within a self-produced extracellular polymeric substance (EPS) matrix, these structured microbial communities demonstrate exceptional resilience, resisting conventional antimicrobial treatments and adapting to, as well as recovering from, environmental and therapeutic stresses, necessitating the development of novel anti-biofilm strategies. This review provides a comprehensive synthesis of biofilm formation, resistance mechanisms, and current and emerging approaches for controlling biofilms, with a primary focus on advancements made over the last decade. Chemical, physical, and biological strategies, including enzymatic degradation, natural compounds, chelating agents, nanoparticles, photodynamic therapy, and probiotics, have demonstrated promising antibiofilm activity. Additionally, combination therapies and targeted drug delivery systems have emerged as viable solutions to enhance the eradication of biofilms. Despite these advancements, challenges such as cytotoxicity, bacterial adaptation, and clinical applicability remain. Addressing these hurdles requires interdisciplinary research to refine existing strategies and develop innovative solutions for effective biofilm management. Full article

Polymeric materials have become important components in prefilled syringes, drug delivery systems, and advanced medical devices. Background/Objectives: Nitrogen dioxide gas is used for the terminal sterilization of drug delivery systems. For the implementation of sterilization methods, compatibility with materials must be demonstrated such that the materials maintain product requirements and specifications after sterilization and at the time of use (i.e., product shelf life). Methods: Commonly used polymers were selected based on their chemical structures to provide insight into the nature of reactions that occur at the temperature and NO₂ concentration levels used in the sterilization process. After exposure to the NO₂ process, materials were evaluated for chemical, mechanical, and biocompatibility properties. Results: In this paper, we demonstrated the compatibility of polymers comprising carbonyl, unsaturated ester, and ketone groups which have been used in medical devices sterilized with NO₂. No significant chemical or physical changes were observed upon the treatment of Amorphous Polyester, Polysulfone (PSU), Polycarbonate (PC), PolyEtherEtherKetone (PEEK), PolyArylEtherKetone (PAEK), and Polypropylene (PP) with NO₂ at a sterilization temperature of 20 °C. At this relatively low sterilization temperature, the reactions of NO₂ with the polymer do not typically occur because the activation energies of these reactions require much higher temperatures. Conclusions: Not all materials will be compatible with NO₂ sterilization, and even with the established data, many devices will need to have their polymers evaluated for compatibility before moving to NO₂ sterilization. These results will provide guidance to device designers selecting materials for new drug delivery devices and to regulators that review the safety and efficacy of these devices. Full article

Background: High expression of nucleolin (NCL) on the surface of tumor cells is closely associated with disease progression and poor prognosis. The aptamer–PROTAC conjugate (APC) technology provides a novel molecular design strategy for the targeted degradation of NCL. Methods: Based on the principles of PROTAC technology and chemical modification techniques, in this study, a series of AS1411-lenalidomide chimeras featuring different linker structures were designed and synthesized for the specific purpose of targeted degradation of NCL. Four AS1411-PROTACs (C1–C4) were successfully constructed via a click chemistry strategy, and their structures were validated. Results: In vitro experimental results showed that C4 exhibited the most optimal activity, significantly downregulating NCL expression and inhibiting the proliferation of breast cancer cells (MCF-7). Notably, the activity of C4 remained unaltered regardless of the annealing process. Mechanistic studies demonstrated that C4 induced NCL degradation through the ubiquitin–proteasome pathway while also promoting apoptosis and cell cycle arrest. In a nude mouse tumor model, C4 displayed potent antitumor efficacy, with no discernible signs of obvious systemic toxicity. Conclusions: This study provides compelling evidence demonstrating that C4 is a highly promising anticancer compound. It also provides important evidence for the development of novel nucleic acid aptamer–PROTAC conjugate drugs for more clinical applications. Full article

Isoflavones are natural compounds abundantly found in soybeans, recognized for their anticancer potential, primarily through their activity as phytoestrogens, which inhibit estrogen receptors. Because cancer remains one of the leading causes of mortality worldwide, identifying compounds that may complement chemotherapy is of great interest. In this review, we summarize advances reported over the past decade regarding the antitumor properties of isoflavones, with emphasis on both in vitro and in vivo effects, as well as chemical, botanical, and pharmacological aspects. A literature search was conducted using the PubMed database covering studies published from January 2014 to April 2025 using the following keywords: ‘isoflavones’ and ‘anticancer’, ‘antitumoral’, and ‘antiproliferative’ and ‘cytotoxicity’. Genistein and daidzein emerge as the most extensively studied isoflavones, with well-documented anticancer activity. Reported anticancer effects include induction of apoptosis, ROS generation, cell cycle arrest, inhibition of cell migration and invasion, loss of mitochondrial membrane potential, modulation of estrogen-related pathways, and antiangiogenic activity. In addition to these mechanistic findings, several isoflavones demonstrated significant tumor growth inhibition in xenograft models, reinforcing their translational potential. Additionally, synergistic interactions with chemotherapeutic drugs and natural compounds and new drug delivery systems have been described. Breast and prostate cancer cell lines were the most investigated due to isoflavones’ estrogen-like effects. However, the cell death mechanisms of newly discovered compounds still require further investigation. Full article

Natural Product Synthesis (NPS) is a cornerstone of organic chemistry, historically rooted in the dual goals of structure elucidation and synthetic strategy development for bioactive compounds. Initially focused on identifying the structures of medicinally relevant natural products, NPS has evolved into a dynamic field with applications in drug discovery, immunotherapy, and smart materials. This evolution has been propelled by advances in reaction design, mechanistic insight, and the integration of green chemistry principles. A particularly promising development in NPS is the use of photochemistry, which harnesses light—a renewable energy source—to drive chemical transformations. Photochemical reactions offer unique excited-state reactivity, enabling synthetic pathways that are often inaccessible through thermal methods. Their precision and sustainability make them ideal for modern synthetic challenges. This review explores a wide range of photochemical reactions, from classical to contemporary, emphasizing their role in total synthesis. By showcasing their potential, the review aims to encourage broader adoption of photochemical strategies in the synthesis of complex natural products, promoting innovation at the intersection of molecular complexity, sustainability, and synthetic efficiency. Full article

Activity-based protein profiling (ABPP) has emerged as a powerful chemical proteomics approach for profiling active amino acid residues, mapping functional proteins, and guiding covalent drug development in complex biological systems. Recent methodological advances have produced several novel formats, including tandem orthogonal proteolysis-ABPP (TOP-ABPP), isotopic tandem orthogonal proteolysis-ABPP (IsoTOP-ABPP), and competitive IsoTOP-ABPP, enabling broader target identification and quantitative analysis for varied experimental purposes. In parallel, chemical probe design has evolved to selectively target specific amino acid residues, such as cysteine (Cys), lysine (Lys), and histidine (His), and to incorporate photoaffinity labeling (PAL) functionalities for capturing transient or weak protein-ligand interactions. Additionally, the integration of cleavable linkers with diverse cleavage mechanisms, including acid/base-mediated, redox-mediated, and photo irradiation mechanisms, has enhanced probe versatility and downstream analytical workflows. This review summarizes recent advances in ABPP methodologies and the design of activity-based probes and PAL probes, emphasizing their implications for future work in chemical biology. Full article